​

Heron Therapeutics (HRTX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HRTX Stock Forecast

Heron Therapeutics (HRTX) stock forecast, based on 2 Wall Street analysts, predicts a 12-month average price target of $7.00, with a high of $9.00 and a low of $5.00. This represents a 319.16% increase from the last price of $1.67.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $9 Avg: $7 Low: $5 Last Closed Price: $1.67

HRTX Stock Rating

Heron Therapeutics stock's rating consensus is Buy, based on 2 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 2 0 2 Strong Sell Sell Hold Buy Strong Buy

HRTX Forecast vs Benchmarks

TypeNameUpside
StockHeron Therapeutics319.16%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$7.00
Last Closing Price$1.67$1.67$1.67
Upside/Downside--319.16%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2512---3
Dec, 2412---3
Nov, 2438---11
Oct, 2438---11
Sep, 2438---11
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 16, 2024Carl ByrnesNorthland Securities$9.00$3.22179.50%438.92%
Mar 13, 2024Serge BelangerNeedham$5.00$3.0166.11%199.40%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jun 12, 2024Rodman & RenshawBuyinitialise
Mar 13, 2024NeedhamBuyBuyhold
Nov 15, 2023NeedhamBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.47$-2.21$-1.24$-0.80-----
Avg Forecast$-2.47$-2.28$-1.85$-0.87$-0.13$-0.05$0.05$0.21$0.36
High Forecast$-2.55$-2.37$-1.92$-0.90$-0.13$-0.05$0.04$0.16$0.34
Low Forecast$-2.40$-2.22$-1.78$-0.83$-0.12$-0.04$0.07$0.26$0.38
Surprise %--3.07%-32.97%-8.05%-----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$88.64M$86.35M$107.67M$127.04M-----
Avg Forecast$87.61M$91.84M$104.90M$123.59M$140.89M$157.96M$180.36M$212.65M$254.90M
High Forecast$85.74M$89.89M$102.11M$122.87M$140.44M$151.87M$175.48M$210.35M$245.50M
Low Forecast$90.02M$94.37M$108.21M$124.31M$141.34M$164.06M$185.23M$214.95M$263.24M
Surprise %1.18%-5.98%2.64%2.80%-----

Net Income Forecast

$-300M $-220M $-140M $-60M $20M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-224.43M$-217.66M$-134.52M$-110.56M-----
Avg Forecast$-232.41M$-228.29M$-225.20M$-110.56M$-17.75M$-6.74M$7.44M$29.01M$49.73M
High Forecast$-278.90M$-273.94M$-270.24M$-132.67M$-18.56M$-7.32M$5.15M$22.15M$47.35M
Low Forecast$-185.93M$-182.63M$-180.16M$-88.45M$-16.95M$-6.15M$9.73M$35.87M$51.84M
Surprise %-3.44%-4.65%-40.27%------

HRTX Forecast FAQ

Is Heron Therapeutics stock a buy?

Heron Therapeutics stock has a consensus rating of Buy, based on 2 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Heron Therapeutics is a favorable investment for most analysts.

What is Heron Therapeutics's price target?

Heron Therapeutics's price target, set by 2 Wall Street analysts, averages $7 over the next 12 months. The price target range spans from $5 at the low end to $9 at the high end, suggesting a potential 319.16% change from the previous close price of $1.67.

How does Heron Therapeutics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Heron Therapeutics stock forecast shows a 319.16% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Heron Therapeutics over the past three months?

  • January 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 27.27% Strong Buy, 72.73% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Heron Therapeutics’s EPS forecast?

Heron Therapeutics's average annual EPS forecast for its fiscal year ending in December is -0.13 for 2024, a -83.75% decrease from the reported $-0.8 in 2023. The prediction for 2025 is $-0.05, $0.05 for 2026, $0.21 for 2027, and $0.36 for 2028.

What is Heron Therapeutics’s revenue forecast?

Heron Therapeutics's average annual revenue forecast for its fiscal year ending in December is $140.89M for 2024, a 10.90% increase from the reported $127.04M in 2023. The forecast for 2025 is $157.96M, $180.36M for 2026, $212.65M for 2027, and $254.9M for 2028.

What is Heron Therapeutics’s net income forecast?

For its fiscal year ending in December, Heron Therapeutics's average annual net income forecast is $-17.753M for 2024, reflecting a -83.94% decrease from the reported $-111M in 2023. The projection for 2025 is $-6.737M, $7.44M for 2026, $29.01M for 2027, and $49.73M for 2028.